Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine

Journal of Ethnopharmacology

Volumn 72, Issue 1-2, 2000, Pages 221-227

  Oh, Ki Wan ^a   Lee, Chong Kil ^a   Kim, Young So ^a   Eo, Seong Kug ^a   Han, Seong Sun ^a  

^a Chungbuk National University   (South Korea)

Author keywords

Antiherpetic activity; Combination index (CI); Ganoderma lucidum; Herpes simplex viruses; Plaque reduction assay

Indexed keywords

ACICLOVIR; GANODERMA LUCIDUM EXTRACT; POLYSACCHARIDE; VIDARABINE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG ISOLATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SCREENING; DRUG SELECTIVITY; HERPES; HERPES SIMPLEX VIRUS; NONHUMAN;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; BASIDIOMYCOTA; CELL SURVIVAL; CERCOPITHECUS AETHIOPS; DRUG SYNERGISM; FUNGAL PROTEINS; HERPESVIRIDAE; PLAQUE ASSAY; POLYSACCHARIDES; PROTEIN BINDING; VERO CELLS; VIDARABINE;

EID: 0034284554     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-8741(00)00254-3     Document Type: Article

References (19)

1. Eo S.K., Kim Y.S., Lee C.K., Han S.S. Antiherpetic activities of various protein bound polysaccharides isolated from Ganoderma lucidum. Journal of Ethnopharmacology. 68:1999;175-181.
2. Hikino H., Konno C., Mirin Y., Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Medica. 51:1985;339-340.
3. Hook E.W. III, Cannon R.O., Nahmias A.J. Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. Journal of Infectious Diseases. 165:1992;251-255.
4. Kim S.S., Kim Y.S. Korean Mushrooms. 1990;298-299 Yupoong, Seoul.
5. Kim B.K., Chung H.S., Chung K.S., Yang M.S. Studies on the antineoplastic components of Korean basidiomycetes. Korean Journal of Mycology. 8:1980;107-113.
6. Kim M.J., Kim H.W., Lee Y.S., Shim M.J., Choi E.C., Kim B.K. Studies on safety of Ganoderma lucidum. Korean Journal of Mycology. 14:(1):1986;49-59.
7. Lapucci A., Macchia M., Parkin A. Antiherpes virus agents: a review. IL Farmaco. 48:(7):1993;871-895.
8. Larder B.A., Darby G., Richman D.D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science. 243:1989;1731-1734.
9. Miyazaki T., Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chemical and Pharmaceutical Bulletin. 29:1981;3611-3616.
10. Nishitoba T., Sato H., Sakamura S. New terpenoids from Ganoderma lucidum and their bitterness. Agricultural Biology and Chemistry. 49:1985;1547-1549.
11. Nishitoba T., Sato H., Kasai T., Kawagishi H., Sakamura S. New bitter C27 and C30 terpenoids from the fungus Ganoderma lucidum (Reishi). Agricultural Biology and Chemistry. 49:1985;1793-1798.
12. Park J.H., Kim H.W., Kim Y.C., Choi E.C., Kim B.K. Studies on antihypertensive components of Ganoderma lucidum in Korea. Korean Journal of Food Hygiene. 2:1987;57-65.
13. Richman D.D., Fischl M.A., Grieco M.H., Gottlieb M.S., Volberdings P.A., Laskin O.L., Leedom J.M., Groopman J.E., Mildvan D., Hirsch M.S., Jackson G.G., Durack D.T., Nusinoff L.S. The AZT Collaborative Working Group. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS-related complex. New England Journal of Medicine. 317:1987;192-197.
14. Scubiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research. 48:1988;4827-4833.
15. Schinazi R.F. Combined therapeutic modalities for viruses-rationale and clinical potential. Chou T.C., Rideout D.C. Molecular Mechanisms of Chemotherapeutic Synergism, Potentiation and Antagonism. 1991;110-181 Academic Press, Orlando, FL.
16. Schinazi R.F., Chou T.-C., Scott R.T., Yao X., Nahmias A.J. Delayed treatment with combination of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis. Antimicrobial Agents and Chemotherapy. 30:(3):1986;491-498.
17. Shannon W.M. Mechanism of action and pharmacology: chemical agents. Galasso G.J., Merigan T.C., Buchanon R.A. Antiviral Agents and Viral Diseases of Man. 1984;55-121 Raven Press, New York.
18. Shigeta S., Mori S., Baba M., Ito M., Honzumi K., Nakamara K., Oshitani H., Numazaki Y., Matsuda A., Obara T., Shuto S., De Clercq E. Antiviral activities of ribavirin, 5-ethynyl-1-β-D-ribofuranosylimidazole-4-carboxamide, and 6′-(R)-6′-C-methylneplanocin A against several ortho- and paramyxoviruses. Antimicrobial Agents and Chemotherapy. 36:(2):1992;435-439.
19. Tachedijian G., Tyseen D., Jardine D., Lorcarnini S., Birch C. Synergistic inhibition of human immunodeficiency virus type I in vitro by interferon alpha and coumermycin A1. Antiviral Chemistry and Chemotherapy. 3:(3):1991;183-188.